Literature DB >> 22542517

KBTBD13 interacts with Cullin 3 to form a functional ubiquitin ligase.

Nyamkhishig Sambuughin1, Wieslaw Swietnicki, Stephen Techtmann, Vera Matrosova, Tarina Wallace, Lev Goldfarb, Ernest Maynard.   

Abstract

Autosomal dominant mutations in BTB and Kelch domain containing 13 protein (KBTBD13) are associated with a new type of Nemaline Myopathy (NEM). NEM is a genetically heterogeneous group of muscle disorders. Mutations causing phenotypically distinct NEM variants have previously been identified in components of muscle thin filament. KBTBD13 is a muscle specific protein composed of an N terminal BTB domain and a C terminal Kelch-repeat domain. The function of this newly identified protein in muscle remained unknown. In this study, we show that KBTBD13 interacts with Cullin 3 (Cul3) and the BTB domain mediates this interaction. Using ubiquitination assays, we determined that KBTBD13 participates in the formation of a Cul3 based RING ubiquitin ligase (Cul3-RL) capable of ubiquitin conjugation. Confocal microscopy of transiently expressed KBTBD13 revealed its co-localization with ubiquitin. Taken together, our results demonstrate that KBTBD13 is a putative substrate adaptor for Cul3-RL that functions as a muscle specific ubiquitin ligase, and thereby implicate the ubiquitin proteasome pathway in the pathogenesis of KBTBD13-associated NEM. Published by Elsevier Inc.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22542517      PMCID: PMC5148137          DOI: 10.1016/j.bbrc.2012.04.074

Source DB:  PubMed          Journal:  Biochem Biophys Res Commun        ISSN: 0006-291X            Impact factor:   3.575


  24 in total

1.  Ubiquitin-dependent degradation of multiple F-box proteins by an autocatalytic mechanism.

Authors:  J M Galan; M Peter
Journal:  Proc Natl Acad Sci U S A       Date:  1999-08-03       Impact factor: 11.205

Review 2.  Protein degradation and protection against misfolded or damaged proteins.

Authors:  Alfred L Goldberg
Journal:  Nature       Date:  2003-12-18       Impact factor: 49.962

3.  Ubiquitination of Keap1, a BTB-Kelch substrate adaptor protein for Cul3, targets Keap1 for degradation by a proteasome-independent pathway.

Authors:  Donna D Zhang; Shih-Ching Lo; Zheng Sun; Geetha M Habib; Michael W Lieberman; Mark Hannink
Journal:  J Biol Chem       Date:  2005-06-27       Impact factor: 5.157

Review 4.  Congenital myopathies: an update.

Authors:  Jessica R Nance; James J Dowling; Elizabeth M Gibbs; Carsten G Bönnemann
Journal:  Curr Neurol Neurosci Rep       Date:  2012-04       Impact factor: 5.081

5.  Ubiquitin-dependent c-Jun degradation in vivo is mediated by the delta domain.

Authors:  M Treier; L M Staszewski; D Bohmann
Journal:  Cell       Date:  1994-09-09       Impact factor: 41.582

Review 6.  Function and regulation of cullin-RING ubiquitin ligases.

Authors:  Matthew D Petroski; Raymond J Deshaies
Journal:  Nat Rev Mol Cell Biol       Date:  2005-01       Impact factor: 94.444

7.  Nemaline myopathy type 6: clinical and myopathological features.

Authors:  Montse Olivé; Lev G Goldfarb; Hee-Suk Lee; Zagaa Odgerel; Andre Blokhin; Laura Gonzalez-Mera; Dolores Moreno; Nigel G Laing; Nyamkhishig Sambuughin
Journal:  Muscle Nerve       Date:  2010-12       Impact factor: 3.217

8.  BTB proteins are substrate-specific adaptors in an SCF-like modular ubiquitin ligase containing CUL-3.

Authors:  Lai Xu; Yue Wei; Jerome Reboul; Philippe Vaglio; Tae-Ho Shin; Marc Vidal; Stephen J Elledge; J Wade Harper
Journal:  Nature       Date:  2003-09-03       Impact factor: 49.962

9.  Targeting of protein ubiquitination by BTB-Cullin 3-Roc1 ubiquitin ligases.

Authors:  Manabu Furukawa; Yizhou Joseph He; Christoph Borchers; Yue Xiong
Journal:  Nat Cell Biol       Date:  2003-10-05       Impact factor: 28.824

10.  Molecular phylogeny of the kelch-repeat superfamily reveals an expansion of BTB/kelch proteins in animals.

Authors:  Soren Prag; Josephine C Adams
Journal:  BMC Bioinformatics       Date:  2003-09-17       Impact factor: 3.169

View more
  21 in total

1.  Mutations in KLHL40 are a frequent cause of severe autosomal-recessive nemaline myopathy.

Authors:  Gianina Ravenscroft; Satoko Miyatake; Vilma-Lotta Lehtokari; Emily J Todd; Pauliina Vornanen; Kyle S Yau; Yukiko K Hayashi; Noriko Miyake; Yoshinori Tsurusaki; Hiroshi Doi; Hirotomo Saitsu; Hitoshi Osaka; Sumimasa Yamashita; Takashi Ohya; Yuko Sakamoto; Eriko Koshimizu; Shintaro Imamura; Michiaki Yamashita; Kazuhiro Ogata; Masaaki Shiina; Robert J Bryson-Richardson; Raquel Vaz; Ozge Ceyhan; Catherine A Brownstein; Lindsay C Swanson; Sophie Monnot; Norma B Romero; Helge Amthor; Nina Kresoje; Padma Sivadorai; Cathy Kiraly-Borri; Goknur Haliloglu; Beril Talim; Diclehan Orhan; Gulsev Kale; Adrian K Charles; Victoria A Fabian; Mark R Davis; Martin Lammens; Caroline A Sewry; Adnan Manzur; Francesco Muntoni; Nigel F Clarke; Kathryn N North; Enrico Bertini; Yoram Nevo; Ekkhard Willichowski; Inger E Silberg; Haluk Topaloglu; Alan H Beggs; Richard J N Allcock; Ichizo Nishino; Carina Wallgren-Pettersson; Naomichi Matsumoto; Nigel G Laing
Journal:  Am J Hum Genet       Date:  2013-06-06       Impact factor: 11.025

Review 2.  Pathophysiological concepts in the congenital myopathies: blurring the boundaries, sharpening the focus.

Authors:  Gianina Ravenscroft; Nigel G Laing; Carsten G Bönnemann
Journal:  Brain       Date:  2014-12-31       Impact factor: 13.501

Review 3.  Drug resistance in Plasmodium.

Authors:  Kasturi Haldar; Souvik Bhattacharjee; Innocent Safeukui
Journal:  Nat Rev Microbiol       Date:  2018-01-22       Impact factor: 60.633

4.  Dysregulation of NRAP degradation by KLHL41 contributes to pathophysiology in nemaline myopathy.

Authors:  Caroline Jirka; Jasmine H Pak; Claire A Grosgogeat; Michael Mario Marchetii; Vandana A Gupta
Journal:  Hum Mol Genet       Date:  2019-08-01       Impact factor: 6.150

5.  Cullin-3 dependent deregulation of ACTN1 represents a new pathogenic mechanism in nemaline myopathy.

Authors:  Jordan Blondelle; Kavya Tallapaka; Jane T Seto; Majid Ghassemian; Madison Clark; Jenni M Laitila; Adam Bournazos; Jeffrey D Singer; Stephan Lange
Journal:  JCI Insight       Date:  2019-04-16

6.  Deleting exon 55 from the nebulin gene induces severe muscle weakness in a mouse model for nemaline myopathy.

Authors:  Coen A C Ottenheijm; Danielle Buck; Josine M de Winter; Claudia Ferrara; Nicoletta Piroddi; Chiara Tesi; Jeffrey R Jasper; Fady I Malik; Hui Meng; Ger J M Stienen; Alan H Beggs; Siegfried Labeit; Corrado Poggesi; Michael W Lawlor; Henk Granzier
Journal:  Brain       Date:  2013-05-28       Impact factor: 13.501

Review 7.  The emerging family of CULLIN3-RING ubiquitin ligases (CRL3s): cellular functions and disease implications.

Authors:  Pascal Genschik; Izabela Sumara; Esther Lechner
Journal:  EMBO J       Date:  2013-08-02       Impact factor: 11.598

Review 8.  Cullin 3-Based Ubiquitin Ligases as Master Regulators of Mammalian Cell Differentiation.

Authors:  Wolfgang Dubiel; Dawadschargal Dubiel; Dieter A Wolf; Michael Naumann
Journal:  Trends Biochem Sci       Date:  2017-12-14       Impact factor: 13.807

Review 9.  The Role of Cullin-RING Ligases in Striated Muscle Development, Function, and Disease.

Authors:  Jordan Blondelle; Andrea Biju; Stephan Lange
Journal:  Int J Mol Sci       Date:  2020-10-26       Impact factor: 5.923

10.  KBTBD13 is an actin-binding protein that modulates muscle kinetics.

Authors:  Josine M de Winter; Joery P Molenaar; Michaela Yuen; Robbert van der Pijl; Shengyi Shen; Stefan Conijn; Martijn van de Locht; Menne Willigenburg; Sylvia Jp Bogaards; Esmee Sb van Kleef; Saskia Lassche; Malin Persson; Dilson E Rassier; Tamar E Sztal; Avnika A Ruparelia; Viola Oorschot; Georg Ramm; Thomas E Hall; Zherui Xiong; Christopher N Johnson; Frank Li; Balazs Kiss; Noelia Lozano-Vidal; Reinier A Boon; Manuela Marabita; Leonardo Nogara; Bert Blaauw; Richard J Rodenburg; Benno Küsters; Jonne Doorduin; Alan H Beggs; Henk Granzier; Ken Campbell; Weikang Ma; Thomas Irving; Edoardo Malfatti; Norma B Romero; Robert J Bryson-Richardson; Baziel Gm van Engelen; Nicol C Voermans; Coen Ac Ottenheijm
Journal:  J Clin Invest       Date:  2020-02-03       Impact factor: 14.808

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.